Evaluating the effect of galantamine HBr using Goal Attainment Scaling (GAS) in a placebo controlled trial of mild to moderate Alzheimer's disease subjects.

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/016/30/03

Funding

  • Institute of Aging: US$294,052.00

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Neurology
  • Medicine (miscellaneous)
  • Ageing